Hypothesis

69 Matching Annotations

Last 7 days
advanced.onlinelibrary.wiley.com advanced.onlinelibrary.wiley.com

Microfluidic Nano-Assembly of Red-Blood-Cell (RBC) Lipids and Components for Engineering Extracellular Vesicles

1
1. scibot 21 Jul 2026
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1002/adhm.202504351
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

advanced.onlinelibrary.wiley.com/doi/10.1002/adhm.202504351
Jul 2026
www.sciencedirect.com www.sciencedirect.com

EFO2 promotes triple-negative breast cancer progression and reduces CD8+ T cell-mediated killing by acetylating USF1 to enhance SLC2A1-mediated glycolysis

1
1. scibot 16 Jul 2026
  
  in Public
  
  RRID: CVCL_1923
  
  DOI: 10.1016/j.bcp.2026.118260
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @nmaralla
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S000629522600599X
May 2026
advanced.onlinelibrary.wiley.com advanced.onlinelibrary.wiley.com

Targeting KDM3B Elicits Anti-tumor Immunity by Alleviating SHP1–mediated STING Suppression in Triple–Negative Breast Cancer

1
1. scibot 28 May 2026
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1002/advs.75846
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

advanced.onlinelibrary.wiley.com/doi/10.1002/advs.75846
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

C-type lectin domain family 5 member A-mediated activation of macrophages via a bispecific antibody enhances anti-HER2 therapy

2
1. scibot 09 May 2026
  
  in Public
  
  CRL-2755
  
  DOI: 10.1136/jitc-2026-014799
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
2. scibot 09 May 2026
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1136/jitc-2026-014799
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC13141162/
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

PD1 blockade-induced DKK1 expression by CD8+ T cells promotes blood-brain barrier permeabilization

1
1. scibot 05 May 2026
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/2159-8290.CD-25-1222
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC13133603/
Apr 2026
onlinelibrary.wiley.com onlinelibrary.wiley.com

Targeting the Vim–PGI2 Pathway Enhances CD8+ T Cell-Mediated Antitumor Immunity in Breast Cancer

1
1. scibot 30 Apr 2026
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1155/humu/8880918
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

onlinelibrary.wiley.com/doi/10.1155/humu/8880918
54.241.53.176 54.241.53.176

cd-25-1222-html.html

1
1. scibot 23 Apr 2026
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/2159-8290.CD-25-1222
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

54.241.53.176/1adfe811e46f1275dd7d57706ff3bd437df9fc0d/cd-25-1222-html.html
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Affinity-optimized TROP2 antibodies support potent antitumor activity in antibody–drug conjugates

1
1. scibot 14 Apr 2026
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1093/abt/tbag011
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC13070557/
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Targeted Delivery of a Potent STING Agonist Payload via an Antibody–Drug Conjugate Drives Robust Antitumor Activity in Preclinical Models

1
1. scibot 12 Apr 2026
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/1535-7163.MCT-25-0108
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC13060629/
Feb 2026
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

FAM135B Deficiency Inhibits Cytotoxic T-cell Activity in Triple-Negative Breast Cancer by Blocking the IFI16-Dependent STING Pathway

1
1. scibot 07 Feb 2026
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/2326-6066.CIR-25-0310
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC12865359/
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Micro‐Organ Chip Deciphers Tumor‐Derived G‐CSF as Remote Commander of Lung Pre‐Metastatic Niche via VEGFA‐KDR Cascade

1
1. scibot 07 Feb 2026
  
  in Public
  
  RRID: CVCL_1923
  
  DOI: 10.1002/advs.202518584
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC12866876/
Dec 2025
www.sciencedirect.com:5037 www.sciencedirect.com:5037

An innovative engineered IL-10 monomer strengthens T cell-mediated anti-tumor responses through anti-PD-1 cis-delivery

1
1. scibot 17 Dec 2025
  
  in Public
  
  ATCCCRL-2755
  
  DOI: 10.1016/j.xcrm.2025.102515
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @areedewitt04
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com:5037/science/article/pii/S2666379125005889
Nov 2025
www.sciencedirect.com www.sciencedirect.com

Non-orthosteric inhibition of enolase 1 impedes growth of triple-negative breast cancer

1
1. scibot 13 Nov 2025
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1016/j.xcrm.2025.102451
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379125005245
www.sciencedirect.com www.sciencedirect.com

StealTHY: An immunogen-free CRISPR platform to expose concealed metastasis regulators in immunocompetent models

1
1. scibot 08 Nov 2025
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1016/j.cell.2025.10.007
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S0092867425011365
Oct 2025
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Overexpression of RUNX2 promotes breast cancer multi-organ metastasis through stabilizing c-Myc

1
1. scibot 17 Oct 2025
  
  in Public
  
  RRID: CVCL_1923
  
  DOI: 10.1038/s41419-025-08018-9
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC12501288/
Sep 2025
www.sciencedirect.com www.sciencedirect.com

Modulation of fibronectin extracellular matrix enhances anti-tumor efficacy of immune checkpoint blockade

1
1. scibot 09 Sep 2025
  
  in Public
  
  CVCL_1923
  
  DOI: 10.1016/j.xcrm.2025.102322
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379125003957
Aug 2025
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

T cells Instruct Immune Checkpoint Inhibitor Therapy Resistance in Tumors Responsive to IL-1 and TNFα Inflammation

1
1. scibot 05 Aug 2025
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/2326-6066.CIR-24-0416
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC11790381/
Jul 2025
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin

1
1. scibot 04 Jul 2025
  
  in Public
  
  CVCL_1923
  
  DOI: 10.1158/0008-5472.CAN-24-0749
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @sonofthor
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC12214879/
Apr 2025
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Trabectedin Enhances the Antitumor Effects of IL-12 in Triple-Negative Breast Cancer

1
1. scibot 04 Apr 2025
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/2326-6066.CIR-24-0775
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC11962391/
52.53.155.43 52.53.155.43

PDF-html.html

1
1. scibot 03 Apr 2025
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/0008-5472.can-24-0749/3563696/can-24-0749.
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @sjvitug
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

52.53.155.43/73f4a278983fd3a9b93fed6443158024ffc69ddc/PDF-html.html
www.sciencedirect.com www.sciencedirect.com

Soluble CTLA-4 regulates immune homeostasis and promotes resolution of inflammation by suppressing type 1 but allowing type 2 immunity

1
1. scibot 01 Apr 2025
  
  in Public
  
  ATCCCat#CRL-2755
  
  DOI: 10.1016/j.immuni.2025.03.004
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @areedewitt04
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1074761325001232
Mar 2025
www.sciencedirect.com www.sciencedirect.com

Tumor-derived arachidonic acid reprograms neutrophils to promote immune suppression and therapy resistance in triple-negative breast cancer

1
1. scibot 29 Mar 2025
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1016/j.immuni.2025.03.002
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1074761325000962
Feb 2025
www.sciencedirect.com www.sciencedirect.com

MIF-ACKR3 causes irreversible fat loss by impairing adipogenesis in cancer cachexia

1
1. scibot 28 Feb 2025
  
  in Public
  
  ATCCCat# CRL-2755
  
  DOI: 10.1016/j.cmet.2025.01.018
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @areedewitt04
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S155041312500018X
www.sciencedirect.com www.sciencedirect.com

Potentiating anti-tumor immunity by re-engaging immune synapse molecules

1
1. scibot 25 Feb 2025
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1016/j.xcrm.2025.101975
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379125000485
aacrjournals.org aacrjournals.org

Triple-negative breast cancer-derived extracellular vesicles promote a hepatic pre-metastatic niche via a cascade of microenvironment remodeling

1
1. scibot 13 Feb 2025
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/1541-7786.MCR-22-0673
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

aacrjournals.org/mcr/article/21/7/726/727474/Triple-Negative-Breast-Cancer-Derived
Jan 2025
aacrjournals.org aacrjournals.org

High Expression of MHC Class I Overcomes Cancer Immunotherapy Resistance Due to IFNγ Signaling Pathway Defects

1
1. scibot 31 Jan 2025
  
  in Public
  
  CRL-2755
  
  DOI: 10.1158/2326-6066.CIR-22-0815
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @areedewitt04
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

aacrjournals.org/cancerimmunolres/article/11/7/895/727496/High-Expression-of-MHC-Class-I-Overcomes-Cancer
www.sciencedirect.com www.sciencedirect.com

Dual ferroptosis induction in N2-TANs and TNBC cells via FTH1 targeting: A therapeutic strategy for triple-negative breast cancer

1
1. scibot 14 Jan 2025
  
  in Public
  
  ATCCCRL-2755
  
  DOI: 10.1016/j.xcrm.2024.101915
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @areedewitt04
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379124006864
52.53.155.43 52.53.155.43

PDF-html.html

1
1. scibot 10 Jan 2025
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/2326-6066.cir-24-0775
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

52.53.155.43/009f00f9e3d39df3c2a4236499ac454ff01f615a/PDF-html.html
www.sciencedirect.com www.sciencedirect.com

Inhibiting intracellular CD28 in cancer cells enhances antitumor immunity and overcomes anti-PD-1 resistance via targeting PD-L1

1
1. scibot 09 Jan 2025
  
  in Public
  
  ATCCCat# CRL-2755
  
  DOI: 10.1016/j.ccell.2024.11.008
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @areedewitt04
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1535610824004434
Dec 2024
www.sciencedirect.com www.sciencedirect.com

Arming Oncolytic M1 Virus with Gasdermin E Enhances Antitumor Efficacy in Breast Cancer

1
1. scibot 19 Dec 2024
  
  in Public
  
  ATCCCRL-2755
  
  DOI: 10.1016/j.isci.2024.111148
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @areedewitt04
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2589004224023733
www.sciencedirect.com www.sciencedirect.com

A commonly inherited human PCSK9 germline variant drives breast cancer metastasis via LRP1 receptor

1
1. scibot 10 Dec 2024
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1016/j.cell.2024.11.009
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S0092867424013266
Sep 2024
www.sciencedirect.com www.sciencedirect.com

FABP4-mediated lipid metabolism promotes TNBC progression and breast cancer stem cell activity

1
1. scibot 25 Sep 2024
  
  in Public
  
  CRL-2755
  
  DOI: 10.1016/j.canlet.2024.217271
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @vtello
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S0304383524006669
www.sciencedirect.com www.sciencedirect.com

Small-molecule GSDMD agonism in tumors stimulates antitumor immunity without toxicity

1
1. scibot 10 Sep 2024
  
  in Public
  
  CRL-2755
  
  DOI: 10.1016/j.cell.2024.08.007
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @vtello
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S0092867424008985
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

PlexinB1 Inactivation Reprograms Immune Cells in the Tumor Microenvironment, Inhibiting Breast Cancer Growth and Metastatic Dissemination

1
1. scibot 05 Sep 2024
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/2326-6066.CIR-23-0289
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC11369622/
Aug 2024
www.sciencedirect.com www.sciencedirect.com

Uncovering therapeutic targets for macrophage-mediated T cell suppression and PD-L1 therapy sensitization

1
1. scibot 27 Aug 2024
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1016/j.xcrm.2024.101698
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @vtello
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379124004191
Jul 2024
www.sciencedirect.com www.sciencedirect.com

Loss of ZNF408 attenuates STING-mediated immune surveillance in breast carcinogenesis

1
1. scibot 24 Jul 2024
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1016/j.isci.2024.110276
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2589004224015013
May 2024
www.sciencedirect.com www.sciencedirect.com

A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell death

1
1. scibot 24 May 2024
  
  in Public
  
  CRL-2755
  
  DOI: 10.1016/j.immuni.2024.04.025
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @abever99
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1074761324002309
www.sciencedirect.com www.sciencedirect.com

Inhibition of protein translational machinery in triple-negative breast cancer as a promising therapeutic strategy

1
1. scibot 10 May 2024
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1016/j.xcrm.2024.101552
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379124002441
Apr 2024
www.sciencedirect.com www.sciencedirect.com

IGSF8 is an innate immune checkpoint and cancer immunotherapy target

1
1. scibot 24 Apr 2024
  
  in Public
  
  Cat# CRL-2755
  
  DOI: 10.1016/j.cell.2024.03.039
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @abever99
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S0092867424003556
Mar 2024
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Generation of murine tumor models refractory to αPD-1/-L1 therapies due to defects in antigen processing/presentation or IFNγ signaling using CRISPR/Cas9

1
1. scibot 06 Mar 2024
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1371/journal.pone.0287733
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC10906908/
Feb 2024
www.sciencedirect.com www.sciencedirect.com

Downregulation of IRF8 in alveolar macrophages by G-CSF promotes metastatic tumor progression

1
1. scibot 29 Feb 2024
  
  in Public
  
  ATCCCat#CRL-2755
  
  DOI: 10.1016/j.isci.2024.109187
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @abever99
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2589004224004085
www.sciencedirect.com www.sciencedirect.com

Preclinical characterization and phase 1 results of ADG106 in patients with advanced solid tumors and non-Hodgkin’s lymphoma

1
1. scibot 08 Feb 2024
  
  in Public
  
  ATCCCRL-2755
  
  DOI: 10.1016/j.xcrm.2024.101414
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @abever99
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379124000375
Jan 2024
transmedcomms.biomedcentral.com transmedcomms.biomedcentral.com

iMN041 is an immunotherapeutic and an effective treatment in mouse xenograft models of pancreatic cancer, renal cancer and triple negative breast cancer

1
1. scibot 25 Jan 2024
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1186/s41231-024-00161-3
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

transmedcomms.biomedcentral.com/articles/10.1186/s41231-024-00161-3
www.sciencedirect.com www.sciencedirect.com

Interferon-stimulated neutrophils as a predictor of immunotherapy response

1
1. scibot 09 Jan 2024
  
  in Public
  
  CRL-2755
  
  DOI: 10.1016/j.ccell.2023.12.005
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @abever99
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1535610823004336
Nov 2023
www.sciencedirect.com www.sciencedirect.com

Anti-tumor effect of PD-L1-targeting antagonistic aptamer-ASO delivery system with dual inhibitory function in immunotherapy

1
1. scibot 17 Nov 2023
  
  in Public
  
  RRID: CVCL_1923
  
  DOI: 10.1016/j.chembiol.2023.10.010
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @jmitrevska
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2451945623003719
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast Cancer

2
1. scibot 03 Nov 2023
  
  in Public
  
  ATTC, CRL-2755
  
  DOI: 10.1158/1535-7163.MCT-23-0303
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
2. scibot 03 Nov 2023
  
  in Public
  
  ATCC (CRL-2755)
  
  DOI: 10.1158/1535-7163.MCT-23-0303
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC10618734/
Oct 2023
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Functional inhibition of the RNA‐binding protein HuR sensitizes triple‐negative breast cancer to chemotherapy

1
1. scibot 07 Oct 2023
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1002/1878-0261.13478
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC10552894/
Sep 2023
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

S-531011, a Novel Anti-Human CCR8 Antibody, Induces Potent Antitumor Responses through Depletion of Tumor-Infiltrating CCR8-Expressing Regulatory T Cells

1
1. scibot 07 Sep 2023
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/1535-7163.MCT-22-0570
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC10477828/
Aug 2023
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Activating Inducible T cell Co-stimulator (ICOS) yields anti-tumor activity alone and in combination with anti-PD-1 checkpoint blockade

3
1. scibot 26 Aug 2023
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/2767-9764.CRC-22-0293
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
2. scibot 26 Aug 2023
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/2767-9764.CRC-22-0293
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
3. scibot 26 Aug 2023
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/2767-9764.CRC-22-0293
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC10430783/
52.53.155.43 52.53.155.43

crc-22-0293-html.html

2
1. scibot 11 Aug 2023
  
  in Public
  
  CVCL_1923
  
  DOI: 10.1158/2767-9764.CRC-22-0293
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
2. scibot 11 Aug 2023
  
  in Public
  
  CVCL_1923
  
  DOI: 10.1158/2767-9764.CRC-22-0293
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

52.53.155.43/4f107a6ec2874295e908f0e6a1a5e9653abe6492/crc-22-0293-html.html
dx.doi.org dx.doi.org

NL-201 upregulates MHC-I expression and intratumoral TCR diversity, and demonstrates robust antitumor activity as monotherapy and in combination with PD-1 blockade

1
1. scibot 09 Aug 2023
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/2326-6066.CIR-22-0304
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

dx.doi.org/10.1158/2326-6066.CIR-22-0304
Jul 2023
52.53.155.43 52.53.155.43

mcr-22-0673-html.html

1
1. scibot 02 Jul 2023
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/1541-7786.MCR-22-0673
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

52.53.155.43/5cc780ea6bc578a6755d505f34922fb0e77b2333/mcr-22-0673-html.html
Feb 2023
aacrjournals.org aacrjournals.org

Bone metastasis initiation is coupled with bone remodeling through osteogenic differentiation of NG2+ cells

1
1. scibot 18 Feb 2023
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/2159-8290.CD-22-0220
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

aacrjournals.org/cancerdiscovery/article/13/2/474/716294/Bone-Metastasis-Initiation-Is-Coupled-with-Bone
Jan 2023
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Vitamin E Enhances Cancer Immunotherapy by Reinvigorating Dendritic Cells via Targeting Checkpoint SHP1

1
1. scibot 07 Jan 2023
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/2159-8290.CD-21-0900
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC9262841/
Dec 2022
52.53.155.43 52.53.155.43

cd-22-0220-html.html

1
1. scibot 03 Dec 2022
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/2159-8290.CD-22-0220
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

52.53.155.43/b725a3c3e409b5ecfb6e439733821b69db1577f5/cd-22-0220-html.html
Jun 2022
52.53.155.43 52.53.155.43

cd-21-0900-html.html

3
1. scibot 30 Jun 2022
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/2159-8290.cd-21-0900
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
2. scibot 25 Jun 2022
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/2159-8290.cd-21-0900
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
3. scibot 22 Jun 2022
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/2159-8290.cd-21-0900
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

52.53.155.43/d5bf83c5c1736aa8a79b5cf8b82689398b415edf/cd-21-0900 (2)-html.html
aacrjournals.org aacrjournals.org

Phosphorylation and stabilization of PD-L1 by CK2 suppresses dendritic cell function

1
1. scibot 14 Jun 2022
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/0008-5472.CAN-21-2300
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

aacrjournals.org/cancerres/article/82/11/2185/699105/Phosphorylation-and-Stabilization-of-PD-L1-by-CK2
Apr 2022
www.sciencedirect.com www.sciencedirect.com

Quiescent cancer cells resist T cell attack by forming an immunosuppressive niche

1
1. scibot 21 Apr 2022
  
  in Public
  
  ATCCCat#CRL-2755
  
  DOI: 10.1016/j.cell.2022.03.033
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @sophiastull
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S0092867422003439
Nov 2021
www.sciencedirect.com www.sciencedirect.com

The allergy mediator histamine confers resistanceto immunotherapy in cancer patients via activationof the macrophage histamine receptor H1

1
1. scibot 25 Nov 2021
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1016/j.ccell.2021.11.002
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1535610821006024
Sep 2021
www.sciencedirect.com www.sciencedirect.com

In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target

1
1. scibot 28 Sep 2021
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1016/j.cell.2021.09.006
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S0092867421010539
Jul 2021
www.nature.com www.nature.com

Selective therapeutic strategy for p53-deficient cancer by targeting dysregulation in DNA repair

1
1. scibot 21 Jul 2021
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1038/s42003-021-02370-0
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

Annotators

scibot

URL

nature.com/articles/s42003-021-02370-0
Sep 2020
cancerimmunolres.aacrjournals.org cancerimmunolres.aacrjournals.org

Anti-VEGF Treatment Enhances CD8+ T-Cell Antitumor Activity by Amplifying Hypoxia

1
1. scibot 05 Sep 2020
  
  in Public
  
  RRID:CVCL_1923
  
  DOI: 10.1158/2326-6066.CIR-19-0360
  
  Resource: (ATCC Cat# CRL-2755, RRID:CVCL_1923)
  
  Curator: @Naa003
  
  SciCrunch record: RRID:CVCL_1923
  
  What is this?
  
  RRIDCUR:Validated RRID:CVCL_1923
Visit annotations in context

Tags

RRID:CVCL_1923

RRIDCUR:Validated

Annotators

scibot

URL

cancerimmunolres.aacrjournals.org/content/8/6/806

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators